MLTX logo

MLTX

Profile

Full Name

MoonLake Immunotherapeutics

Ticker Symbol

MLTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Switzerland

IPO

October 20, 2020

Indexes

Not included

Website

http://www.moonlaketx.com

Employees

100

Key Details

Price

$36.97(+0.54%)

Market cap

$2.34B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.89(-158.90% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$36.97
MLTX price is $36.97

30-Day Relative Volume

0.60
MLTX 30-day relative volume is 0.60

Price Performance

Price Today change

+0.54%
MLTX price is up +0.54% today

Price YTD change

-31.73%
MLTX price is down -31.73% since January 1st

Price 1-year change

-15.01%
MLTX price is down -15.01% year-on-year

Price 3-year change

+632.08%
MLTX price is up +632.08% over the past 3 years

Price Range

Price All-time high

$64.98
MLTX price is currently -43.11% below its historical high of $64.98

Price 3-year low

$4.25
MLTX price is currently +769.88% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.34B
MLTX market capitalization is $2.34 billion

Market cap 3-year change

+1154.63%
MLTX market capitalization is up +1154.63% over the past 3 years

Market cap All-time high

$3.86B
MLTX market capitalization is currently -39.43% below its historical high of $3.86 billion

Market cap sector rank

84.54%
MLTX market capitalization is higher than 84.54% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.65%
MLTX shares outstanding is up +0.65% year-on-year

Shares Outstanding 3-Year Change

+71.38%
MLTX shares outstanding is up +71.38% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.91
MLTX beta is 0.91

200-day SMA

$46.42
MLTX price is currently -20.36% below its 200-day simple moving average

50-day SMA

$39.80
MLTX price is currently -7.11% below its 50-day simple moving average

RSI

47.53
MLTX 14-day relative strength index is 47.53

Volume

0.60
MLTX 30-day relative volume is 0.60

ATR

$2.63
MLTX average true range is $2.63

10-day Historical Volatility

79.10%
MLTX 10-day historical volatility is 79.10%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
MLTX annual revenue value is unknown

Revenue Analysts estimate

-
MLTX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
MLTX annual revenue 1-year change is unknown

Revenue Sector rank

-
MLTX annual revenue is unknown

EPS

EPS

-$1.89
MLTX annual earnings per share is -$1.89

EPS Analysts estimate

-$3.09
MLTX annual earnings per share is currently -38.87% lower than the consensus analysts' forecast

EPS 1-year change

-158.9%
MLTX annual earnings per share is down -158.9% year-on-year

EPS Sector rank

39.77%
MLTX annual earnings per share is higher than 39.77% of companies in Healthcare sector

Profit

Gross profit

-
MLTX annual gross profit value is unknown

Gross margin

-
MLTX annual gross profit margin value is unknown

Operating profit

-$143.09M
MLTX annual operating income is -$143.09 million

Operating margin

-
MLTX annual operating profit margin value is unknown

Net income

-$118.94M
MLTX annual net profit is -$118.94 million

Net margin

-
MLTX annual net profit margin value is unknown

Expenses

Total expenses

$143.09M
MLTX annual total expenses is $143.09 million

Operating expenses

$143.09M
MLTX annual total operating expenses is $143.09 million

Cost of goods sold

-
MLTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$30.32M
MLTX annual SGA is $30.32 million

Depreciation and amortization

$1.38M
MLTX annual depreciation & amortization is $1.38 million

Interest expense

-
MLTX annual interest expense value is unknown

Income tax

$282.20K
MLTX annual income tax is $282.20 thousand

EBIT & EBITDA

EBIT

-$143.09M
MLTX annual earnings before interest & taxes is -$143.09 million

EBITDA

-$141.71M
MLTX annual EBITDA is -$141.71 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$477.93M
MLTX annual total assets is $477.93 million

Non current assets

$3.64M
MLTX annual long term assets is $3.64 million

Current assets

$474.29M
MLTX annual total current assets is $474.29 million

Cash and cash equivalents

$180.43M
MLTX annual cash & cash equivalents is $180.43 million

Accounts receivable

-
MLTX annual accounts receivable value is unknown

Inventory

-
MLTX annual inventory value is unknown

Liabilities

Total liabilities

$24.54M
MLTX annual total liabilities is $24.54 million

Long term liabilities

$2.08M
MLTX annual total long term liabilities is $2.08 million

Current liabilities

$22.46M
MLTX annual total current liabilities is $22.46 million

Accounts payable

$8.68M
MLTX annual accounts payable is $8.68 million

Debt

Total debt

$2.83M
MLTX annual total debt is $2.83 million

Total debt 1-year change

-23.48%
MLTX annual total debt is down -23.48% year-on-year

Long term debt

$1.46M
MLTX annual long term debt is $1.46 million

Short term debt

$1.37M
MLTX annual short term debt is $1.37 million

Equity & Capital

Shareholders equity

$446.82M
MLTX annual stockholders equity is $446.82 million

Book value

$446.82M
MLTX annual book value is $446.82 million

Retained earnings

-$235.59M
MLTX annual retained earnings is -$235.59 million

Working capital

$451.82M
MLTX annual working capital is $451.82 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$116.59M
MLTX annual cash flow from operations is -$116.59 million

Cash from operations 1-year change

-172.54%
MLTX annual cash flow from operations is down -172.54% year-on-year

Cash from investing

-$205.60M
MLTX annual cash flow from investing activities is -$205.60 million

Cash from investing 1-year change

-716.36%
MLTX annual cash flow from investing activities is down -716.36% year-on-year

Cash from financing

$51.31M
MLTX annual cash flow from financing activities is $51.31 million

Cash from financing 1-year change

-89.3%
MLTX annual cash flow from financing activities is down -89.3% year-on-year

CAPEX

CAPEX

-
MLTX annual capital expenditures value is unknown

CAPEX 1-year change

-
MLTX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$117.11M
MLTX annual free cash flow is -$117.11 million

Free cash flow 1-year change

-171.94%
MLTX annual free cash flow is down -171.94% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
MLTX annual gross profit margin value is unknown

Operating margin

-
MLTX annual operating profit margin value is unknown

Net margin

-
MLTX annual net profit margin value is unknown

ROA & ROE

ROA

-24.89%
MLTX annual return on assets is -24.89%

ROE

-26.62%
MLTX annual return on equity is -26.62%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MLTX price to earnings ratio value is unknown

PE ratio Sector rank

-
MLTX price to earnings ratio is unknown

PB Ratio

PB ratio

5.24
MLTX price to book ratio is 5.24

PB ratio Sector rank

84.2%
MLTX price to book ratio is higher than 84.2% of companies in Healthcare sector

PS Ratio

PS ratio

-
MLTX price to sales ratio value is unknown

PS ratio Sector rank

-
MLTX price to sales ratio is unknown

Enterprise value

Enterprise value

$2.16B
MLTX enterprise value is $2.16 billion

Enterprise value Sector rank

82.96%
MLTX enterprise value is higher than 82.96% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-15.26
MLTX EV/EBITDA is -15.26

EV/EBITDA Sector rank

8.01%
MLTX EV/EBITDA is higher than 8.01% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

21.11
MLTX annual current ratio is 21.11

Quick ratio

-
MLTX annual quick ratio value is unknown

Leverage

Debt to equity

0.01
MLTX annual debt to equity ratio is 0.01

Interest coverage ratio

-
MLTX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
MLTX piotroski f-score value is unknown

Altman Z-Score

-
MLTX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 18, 25 RBC Capital
Outperform
Feb 27, 25 Needham
Buy
Feb 27, 25 HC Wainwright & Co.
Buy
Feb 27, 25 Goldman Sachs
Buy
Jan 17, 25 Goldman Sachs
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 15, 24 HC Wainwright & Co.
Buy
Sep 23, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

ACHC logo
Acadia Healthcare (ACHC)
TWST logo
Twist Bioscience (TWST)
IBRX logo
ImmunityBio (IBRX)
AGL logo
agilon health (AGL)
APLS logo
Apellis Pharmaceuticals (APLS)
RXRX logo
Recursion Pharmaceuticals (RXRX)
CERT logo
Certara (CERT)
AMRX logo
Amneal Pharmaceuticals (AMRX)
HCM logo
HUTCHMED (China) Limited (HCM)
  • What is the ticker symbol for MoonLake Immunotherapeutics?
  • Does MoonLake Immunotherapeutics pay dividends?
  • What sector is MoonLake Immunotherapeutics in?
  • What industry is MoonLake Immunotherapeutics in?
  • What country is MoonLake Immunotherapeutics based in?
  • When did MoonLake Immunotherapeutics go public?
  • Is MoonLake Immunotherapeutics in the S&P 500?
  • Is MoonLake Immunotherapeutics in the NASDAQ 100?
  • Is MoonLake Immunotherapeutics in the Dow Jones?
  • When was MoonLake Immunotherapeutics's last earnings report?
  • When does MoonLake Immunotherapeutics report earnings?
  • Should I buy MoonLake Immunotherapeutics stock now?

What is the ticker symbol for MoonLake Immunotherapeutics?

The ticker symbol for MoonLake Immunotherapeutics is NASDAQ:MLTX

Does MoonLake Immunotherapeutics pay dividends?

No, MoonLake Immunotherapeutics does not pay dividends

What sector is MoonLake Immunotherapeutics in?

MoonLake Immunotherapeutics is in the Healthcare sector

What industry is MoonLake Immunotherapeutics in?

MoonLake Immunotherapeutics is in the Biotechnology industry

What country is MoonLake Immunotherapeutics based in?

MoonLake Immunotherapeutics is headquartered in Switzerland

When did MoonLake Immunotherapeutics go public?

MoonLake Immunotherapeutics's initial public offering (IPO) was on October 20, 2020

Is MoonLake Immunotherapeutics in the S&P 500?

No, MoonLake Immunotherapeutics is not included in the S&P 500 index

Is MoonLake Immunotherapeutics in the NASDAQ 100?

No, MoonLake Immunotherapeutics is not included in the NASDAQ 100 index

Is MoonLake Immunotherapeutics in the Dow Jones?

No, MoonLake Immunotherapeutics is not included in the Dow Jones index

When was MoonLake Immunotherapeutics's last earnings report?

MoonLake Immunotherapeutics's most recent earnings report was on Feb 26, 2025

When does MoonLake Immunotherapeutics report earnings?

The next expected earnings date for MoonLake Immunotherapeutics is May 7, 2025

Should I buy MoonLake Immunotherapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page